Welcome to Amayeza Information Centre

 The word “Amayeza” means “Medicine” in the Xhosa language.

We are an independant medicine information centre that aims to provide reliable, accurate, objective, and up-to-date information on medicine to pharmacists and other health care professionals across South Africa.

Please note that our services are subscription-based. In order for you to benefit from our up-to-date medicine information, you will need to be a subscriber of Amayeza Information Services. For more information regarding subscriptions, click here





With the approach of the holiday season in December, it is important for travellers visiting any of the malaria areas within southern Africa or elsewhere to take appropriate precautions and maintain a high index of
suspicion for symptoms of malaria on their return.









Archived information 



Every year in South Africa, there is an increase in influenza transmission during winter, called the influenza season. The National Institute for Communicable Diseases (NICD) monitors the influenza season each year through its surveillance programmes. As at June 2019, most of the influenza samples detected by three surveillance programmes, have been identified as influenza A (H3N2 strain). This strain is contained in the influenza vaccine, available from your local pharmacy.

A further point to take note from the NICD: “There have been several recent media reports of outbreaks of so-called “swine flu” in schools. The term “swine flu” is an incorrect term as this refers to a disease of pigs. This term is sometimes incorrectly used to refer to the influenza A (H1N1)-pdm09 influenza subtype which emerged in 2009. This subtype of influenza is a normal seasonal influenza strain and behaves like any other type of influenza.”

For more information, visit the NICD: http://www.nicd.ac.za/diseases-a-z-index/influenza/


Useful links:




Data Privacy Statement

Amayeza Information Services stores any personal information to enable us to address the enquiry, or other such matters that have been raised, and to document our response. The information will be retained in a secure server and will only be used for this purpose, unless required for legal proceedings. If reporting an adverse event, the information provided will be used in order to meet regulatory requirements in relation to the safety of medicines. In accordance with applicable law, you may have a right to access and correct your information. If you would prefer that Amayeza does not store your personal data, please let us know.



Last updated: 09 July 2019

Comments are closed.